BPC-157 Dosage: A Physician-Supervised Guide to Protocols, Timing, and Safe Use

If you're searching for BPC-157 dosage information, you've probably already done your homework. You've read the forums, scanned a few research summaries, and found a dozen different numbers — all presented with the same confident authority, none of them attached to a physician who has actually supervised a clinical protocol.

That's the gap this post exists to close.

Dr. George Ibrahim is a board-certified urologist, a Duke University School of Medicine graduate, and a Fellow of the American Academy of Anti-Aging Medicine with more than 30 years in clinical practice. He has supervised peptide therapy protocols for patients across Asheville, NC and Greenville, SC. What follows reflects how BPC-157 is actually used in a physician-led clinical setting — not forum consensus, not bodybuilding community averages, and not dosage calculators built by people without a medical license.

If you want the numbers without context, there are plenty of other sites for that. If you want to understand the protocol behind the numbers, keep reading.

What Is BPC-157? A Brief Clinical Overview

BPC-157 — Body Protection Compound 157 — is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. It was first studied for its role in gastrointestinal healing, and what researchers found was striking enough to expand the investigation considerably.

Today, clinical interest in BPC-157 extends to musculoskeletal repair, tendon and ligament healing, neurological recovery, and systemic anti-inflammatory effects. The mechanism appears to involve upregulation of growth hormone receptors and promotion of angiogenesis — the formation of new blood vessels — in damaged tissue.

Here's what you need to know from a compliance standpoint before we go further: BPC-157 is a compounded peptide. It is not FDA-approved for any specific medical indication. It is available through licensed compounding pharmacies under a physician's prescription and supervision. At Biltmore Restorative Medicine & Aesthetics, every BPC-157 protocol is designed, prescribed, and monitored by Dr. Ibrahim. That distinction matters — and we'll come back to it.

BPC-157 Dosage — General Clinical Ranges

The standard clinical range for BPC-157 in injectable form is 250 to 500 micrograms (mcg) per day, administered via subcutaneous or intramuscular injection. Most protocols use once-daily dosing, though twice-daily protocols are used in acute injury scenarios where accelerated healing is the goal.

The direct answer to "what is the correct BPC-157 dosage?" Most physician-supervised protocols start at 250 mcg daily and adjust based on patient response, bodyweight, the specific indication being addressed, and injection method. There is no single universal dose — a patient using BPC-157 for gut health will likely be dosed differently than one recovering from a knee injury.

Indication	Typical Dose Range	Frequency
General healing / systemic	250–500 mcg	Once daily
Musculoskeletal / joint injury	250–500 mcg	Once or twice daily
Tendon repair	200–350 mcg	Once daily
GI health (injectable)	250–500 mcg	Once daily
GI health (oral)	500–1,000 mcg	Once daily

 

These are clinical reference ranges. Your physician determines your actual protocol.

Dosage by Indication — How Protocols Differ

BPC-157 is not a one-size-fits-all compound. The right dose, delivery method, and duration depend on what you're treating, where the injury is, and how your body responds over time.

BPC-157 Dosage for Joint Injuries (Knee, Hip, Shoulder)

For joint-specific applications — knee injuries, hip degeneration, shoulder impingement — the clinical approach involves both dose and injection site strategy. Injecting close to the injury site (peri-articular or local subcutaneous) may produce more targeted tissue effects than distal injection.

A standard protocol for joint injury uses 250–500 mcg daily, with injections placed near the affected joint when tolerable. Duration is typically 4 to 8 weeks, with reassessment at the halfway point. Many patients report meaningful improvement in comfort and mobility within the first two to four weeks, though individual response varies considerably.

BPC-157 Dosage for Tennis Elbow and Tendon Repair

Tendon-specific applications — tennis elbow (lateral epicondylitis), Achilles tendinopathy, rotator cuff tendinitis — often respond to the lower end of the dosage range. The tissue involved is less vascular than muscle or bone, and BPC-157's proposed mechanism of promoting tendon cell migration and collagen synthesis appears to require less compound to initiate a response.

For tennis elbow specifically, physician-supervised protocols typically use 200–350 mcg daily, injected subcutaneously near the elbow or in the forearm. A full protocol runs 6 to 8 weeks. Patients often notice reduced pain and improved grip strength around week four, with continued improvement through cycle completion. Results vary by individual.

BPC-157 Dosage for Gut Health and GI Healing

This is where BPC-157's origin story becomes clinically relevant again. For gastrointestinal applications — including leaky gut, inflammatory bowel symptoms, and post-surgical GI recovery — oral BPC-157 may be the more appropriate delivery method.

Oral bioavailability for peptides is typically poor due to enzymatic degradation in the GI tract. BPC-157 is one of the few peptides with evidence suggesting it may retain activity when taken orally, precisely because it was derived from gastric proteins. Oral protocols often use 500–1,000 mcg daily in capsule form. Injectable BPC-157 can also support GI healing systemically when oral is not available. Your prescribing physician determines which form is appropriate for your presentation.

BPC-157 and TB-500 Stack — Dosage Considerations

BPC-157 is frequently combined with TB-500 (Thymosin Beta-4) in what has become one of the more widely discussed peptide stacks in restorative medicine. The rationale: BPC-157 promotes localized tissue repair and angiogenesis; TB-500 contributes systemic anti-inflammatory effects and cell migration. Together, they may support recovery more comprehensively than either does alone.

When stacking BPC-157 and TB-500, dosing typically looks like this: BPC-157 remains in the 250–500 mcg daily range; TB-500 is usually dosed at 2–2.5 mg twice weekly during an initial loading phase, followed by a maintenance phase. Combined protocols require physician oversight — not because either compound is uniquely dangerous in isolation, but because layered peptide protocols need to be monitored for cumulative response and adjusted based on how your body is actually responding.

Do not build your own stack from a forum protocol. A physician who knows your bloodwork, your history, and your goals builds a fundamentally different — and more effective — protocol than one assembled from research threads.

How to Inject BPC-157 — Technique and Reconstitution

BPC-157 is supplied as a lyophilized (freeze-dried) powder and must be reconstituted before use. Here is the standard clinical process:

Reconstitution:

1. Wipe the tops of both the BPC-157 vial and the bacteriostatic water vial with an alcohol swab
2. Draw the appropriate volume of bacteriostatic water into a syringe — typically 1–2 mL, depending on your desired concentration
3. Inject the bacteriostatic water slowly into the BPC-157 vial, directing the liquid down the inside wall of the vial rather than directly onto the powder
4. Do not shake — gently swirl until the powder is fully dissolved
5. The reconstituted solution should be clear; discard if cloudy or particulate
6. Store reconstituted BPC-157 in the refrigerator; use within 30 days

Injection technique:

• Subcutaneous (subQ) is most common — pinch the skin of the abdomen or near the injury site, insert a 29–31 gauge insulin needle at a 45-degree angle, and inject slowly
• Intramuscular (IM) is used in some protocols; your physician will specify when this is appropriate
• For local injury applications, injecting subcutaneously within several inches of the affected joint or tendon may support more targeted delivery
• Rotate injection sites to prevent localized irritation

Frequency: Most protocols use once-daily injection in the morning. Twice-daily protocols (morning and evening) are used in acute-phase injury recovery under physician direction.

Your compounding pharmacy will provide your BPC-157 with specific reconstitution and dosing instructions tailored to the concentration they prepared. Follow those instructions. If anything is unclear, call the pharmacy or Dr. Ibrahim's office before proceeding.

BPC-157 Cycle Length — How Long Should a Protocol Run?

The direct answer: Most physician-supervised BPC-157 cycles run 4 to 12 weeks, depending on the indication.

• Acute injury recovery: 4–6 weeks, then reassessment
• Chronic tendon or joint conditions: 8–12 weeks
• GI healing protocols: 4–8 weeks
• General systemic / longevity protocols: 8–12 weeks with a structured cycle off

The concept of "cycling off" — taking a break between protocol runs — exists to prevent receptor desensitization and to allow your physician to assess where you are before continuing. BPC-157 is not a compound you run indefinitely without monitoring. A physician who is tracking your progress can tell you whether to continue, adjust, or pause.

At Biltmore, cycle completion is followed by a reassessment appointment. That conversation determines whether you repeat the protocol, modify it, or move to a maintenance approach.

Safety, Side Effects, and What to Watch For

BPC-157 has a favorable safety profile in the existing research literature, which consists primarily of animal studies and emerging clinical observations. No serious adverse events have been documented in controlled research at therapeutic doses.

Reported side effects in clinical use are generally mild:

• Nausea — most common; typically resolves within the first week
• Injection site reactions — redness, mild swelling, or irritation at the injection site
• Dizziness or lightheadedness — reported infrequently; typically brief

Contact your prescribing physician if you experience persistent nausea, signs of infection at the injection site (increasing redness, warmth, swelling, discharge), or any systemic symptoms that concern you.

One more thing worth stating directly: the risk profile of self-dosed BPC-157 sourced from unregulated online suppliers is categorically different from physician-supervised BPC-157 obtained through a licensed compounding pharmacy. Product purity, concentration accuracy, and sterility are not guaranteed outside of regulated pharmacy channels. That is not a minor distinction.

Why Physician Supervision Changes the Outcome

There is a version of this conversation where someone hands you a dosage number and sends you on your way. That is not what we do at Biltmore Restorative Medicine & Aesthetics, and it is not what Dr. Ibrahim built this practice to be.

A forum gives you a number. A physician gives you a protocol.

The difference is this: Dr. Ibrahim reviews your health history, your current labs, your goals, and the specific injury or condition you're addressing before a single unit of BPC-157 is prescribed. The dose, the delivery method, the cycle length, the injection technique — all of it is calibrated to you as an individual. That is what physician-supervised peptide therapy looks like in a clinical setting.

It also means you have someone to call when you have a question at week three. Someone who can read your follow-up labs and tell you what the numbers mean. Someone whose license, training, and professional reputation are attached to your outcome.

If you're in Asheville, NC or Greenville, SC — or willing to travel — and you're serious about doing this right, that consultation is worth the conversation. Learn more about our peptide therapy program in Asheville or our peptide therapy program in Greenville, SC.

The Bottom Line

BPC-157 is one of the most clinically promising peptides in restorative medicine. The research basis is real, the clinical interest is growing, and for the right patient with the right protocol, the outcomes can be significant.

But the results are only as good as the protocol behind them. A dosage number without clinical context is not a protocol. It's a starting point — and starting points without physician oversight are where outcomes go sideways.

At Biltmore Restorative Medicine & Aesthetics, peptide therapy is physician-designed, physician-supervised, and built around your specific health picture. That's not a marketing line. It's how Dr. Ibrahim has practiced medicine for more than 30 years.

If you're ready to do this right, the next step is a conversation.